Clinical Trials Browser

Suspended × OTHER × Stomach Neoplasms × Clear all

NCT05400122 2025-11-12

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Phase 1 Suspended

GastrointestinalLymphoidMyeloidOther hematologic neoplasmPlasma cell

Esophageal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasm Metastasis, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05101616 2024-03-07

A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

Phase 1/2 Suspended

Gastrointestinal

Stomach Neoplasms

NCT05233007 2024-02-08

Upper GI Serial Tumour Biopsies

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT01342653 2016-11-21

HIPEC

Phase 2 Suspended

GastrointestinalGynecologic

Carcinoma, Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT01723306 2016-06-14

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

Phase 2 Suspended

GastrointestinalThoracic

Lung Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02686424 2016-02-23

ONCO-RD010CRT

Gastrointestinal

Stomach Neoplasms

NCT00209729 2010-05-26

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Phase 1/2 Suspended

Gastrointestinal

Stomach Neoplasms

NCT00568529 2010-05-26

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Phase 2 Suspended

Gastrointestinal

Stomach Neoplasms